Survey on the Effectiveness of the PLAB Examination in Continuing Clinical Education in British Doctors.

October 18, 2022 updated by: Samer Makki Mohamed Al-Hakkak, Jabir Ibn Hayyan Medical University

Survey the Effectiveness of PLAB Examination in Further Clinical Training in the United Kingdom

Online survey for all international medical graduate doctors who decided to get a job in the UK; they must do GMC registration.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United Kingdom
    • West Suffolk
      • Westbury On Severn, West Suffolk, United Kingdom
        • West Suffolk Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

cross-sectional

Description

Inclusion Criteria:

  • Post-PLAB exam and GMC registration international medical graduate
  • Candidates who practise in NHS as FY1 and FY2

Exclusion Criteria:

  • Pass PLAB one exam
  • Pass PLAB two exam
  • Candidates pass PLAB one and two but still not working in NHS

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
cross section online google form questioner
Time Frame: 1 month
cross section online google form questioner
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Jabir Ibn Hayyan Medical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 3, 2022

Primary Completion (Actual)

June 4, 2022

Study Completion (Actual)

June 30, 2022

Study Registration Dates

First Submitted

May 2, 2022

First Submitted That Met QC Criteria

May 2, 2022

First Posted (Actual)

May 5, 2022

Study Record Updates

Last Update Posted (Actual)

October 20, 2022

Last Update Submitted That Met QC Criteria

October 18, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • PLAB

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on International Medical Graduate Student

Clinical Trials on non interventional

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Türkiye

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe